Related Experiment Video
Updated: Sep 21, 2025

CD Spectroscopy to Study DNA-Protein Interactions
Published on: February 10, 2022
The SWI/SNF ATPase BRG1 facilitates multiple pro-tumorigenic gene expression programs in SMARCB1-deficient cancer
Kylie C Moe1, Jack N Maxwell1, Jing Wang2,3
1Department of Biology, Middle Tennessee State University, Murfreesboro, TN, 32132, USA.
Abstract:
Malignant rhabdoid tumor (MRT) is driven by the loss of the SNF5 subunit of the SWI/SNF chromatin remodeling complex and then thought to be maintained by residual SWI/SNF (rSWI/SNF) complexes that remain present in the absence of SNF5. rSWI/SNF subunits colocalize extensively on chromatin with the transcription factor MYC, an oncogene identified as a novel driver of MRT. Currently, the role of rSWI/SNF in modulating MYC activity has neither been delineated nor has a direct link between rSWI/SNF and other oncogenes been uncovered. Here, we expose the connection between rSWI/SNF and oncogenic processes using a well-characterized chemical degrader to deplete the SWI/SNF ATPase, BRG1. Using a combination of gene expression and chromatin accessibility assays we show that rSWI/SNF complexes facilitate MYC target gene expression. We also find that rSWI/SNF maintains open chromatin at sites associated with hallmark cancer genes linked to the AP-1 transcription factor, suggesting that AP-1 may drive oncogenesis in MRT. Interestingly, changes in MYC target gene expression are not overtly connected to the chromatin remodeling function of rSWI/SNF, revealing multiple mechanisms used by rSWI/SNF to control transcription. This work provides an understanding of how residual SWI/SNF complexes may converge on multiple oncogenic processes when normal SWI/SNF function is impaired.
Insights
Residual SWI/SNF complexes maintain malignant rhabdoid tumor (MRT) growth by facilitating MYC oncogene expression and maintaining open chromatin at AP-1-driven cancer genes. This reveals new therapeutic targets for MRT.
Area of Science:
- Cancer Biology
- Chromatin Remodeling
- Epigenetics
Background:
- Malignant rhabdoid tumor (MRT) arises from SNF5 loss in SWI/SNF complexes.
- Residual SWI/SNF (rSWI/SNF) complexes and MYC oncogene are present in MRT.
- The role of rSWI/SNF in MYC activity and oncogenesis is unclear.
Purpose of the Study:
- To investigate the role of rSWI/SNF in MYC-driven oncogenesis in MRT.
- To uncover direct links between rSWI/SNF and other oncogenes in MRT.
Main Methods:
- Utilized a chemical degrader to deplete the SWI/SNF ATPase, BRG1.
- Performed gene expression and chromatin accessibility assays.
Main Results:
- Demonstrated that rSWI/SNF facilitates MYC target gene expression.
- Showed rSWI/SNF maintains open chromatin at AP-1-associated cancer gene sites.
- Observed that MYC target gene expression changes are not solely linked to rSWI/SNF chromatin remodeling.
Conclusions:
- rSWI/SNF complexes contribute to MRT oncogenesis through multiple mechanisms.
- rSWI/SNF influences MYC activity and maintains open chromatin at AP-1-driven sites.
- This study provides insights into rSWI/SNF's role in impaired SWI/SNF function and cancer.
More Related Videos
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
TGF - β Signaling Pathway
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Abnormal Proliferation
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:

